Literature DB >> 1712399

Workshop on screening for hepatocellular carcinoma.

B J McMahon1, T London.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1712399     DOI： 10.1093/jnci/83.13.916

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

Review 1.  Cancer screening in renal transplant recipients: what is the evidence?

Authors:  Germaine Wong; Jeremy R Chapman; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

2.  Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients.

Authors:  M W Oberle; C N Shapiro; A P Lanier
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

3.  Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.

Authors:  Jessica A Davila; Robert O Morgan; Peter A Richardson; Xianglin L Du; Katherine A McGlynn; Hashem B El-Serag
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

4.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

5.  The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.

Authors:  Stephanie D Chao; Ellen T Chang; Phuoc V Le; Wijan Prapong; Michaela Kiernan; Samuel K S So
Journal:  J Immigr Minor Health       Date:  2007-11-08

6.  Primary liver cancer in a high-incidence area in north Italy: etiological hypotheses arising from routinely collected data.

Authors:  R Chiesa; F Donato; N Portolani; M Favret; V Tomasoni; G Nardi
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

7.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

Review 8.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

9.  Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients.

Authors:  Münevver Demir; Friederike Grünewald; Sonja Lang; Christoph Schramm; Andrea Bowe; Vera Mück; Fabian Kütting; Tobias Goeser; Hans-Michael Steffen
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.